Evidence map›Paper›PMID 35463013›Full record

ArticleFrontiers in medicine2022

Archetypal Analysis of Injury in Kidney Transplant Biopsies Identifies Two Classes of Early AKI.

Philip F Halloran, Georg A Böhmig, Jonathan Bromberg, Gunilla Einecke, Farsad A Eskandary, Gaurav Gupta, Marek Myslak, Ondrej Viklicky, Agnieszka Perkowska-Ptasinska, Katelynn S Madill-Thomsen and 1 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Frontiers in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01299168 (Multi-centric Observational Study to Analyse the Diagnostic Molecular Features in the Clinical Setting of Kidney Allograft Biopsies), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01299168 recruitingnot on this map

Multi-centric Observational Study to Analyse the Diagnostic Molecular Features in the Clinical Setting of Kidney Allograft Biopsies

TypeobservationalSponsorUniversity of AlbertaRan2011 to 2028Enrolled500ConditionsValidation Study of Molecular Diagnostic System, Development of Reporting System for Molecular Diagnosis, Incorporate Molecular Diagnosis Into Diagnostic Standards
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Observational
  2. Observational
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 9 institutions in 6 countries.

Philip F HalloranAlberta Transplant Applied Genomics Centre, Edmonton, AB, Canada.
Georg A BöhmigDivision of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
Jonathan BrombergDepartment of Surgery, University of Maryland, Baltimore, MD, United States.
Gunilla EineckeDepartment of Nephrology, Hannover Medical School, Hannover, Germany.
Farsad A EskandaryDivision of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
Gaurav GuptaDivision of Nephrology, Virginia Commonwealth University, Richmond, VA, United States.
Marek MyslakDepartment of Clinical Interventions, Department of Nephrology and Kidney Transplantation Samodzielny Publiczny Wojewódzki Szpital Zespolony (SPWSZ) Hospital, Pomeranian Medical University, Szczecin, Poland.
Ondrej ViklickyDepartment of Nephrology and Transplant Center, Institute for Clinical and Experimental Medicine, Prague, Czechia.
Agnieszka Perkowska-PtasinskaDepartment of Transplantation Medicine, Nephrology and Internal Diseases, Medical University of Warsaw, Warsaw, Poland.
Katelynn S Madill-ThomsenAlberta Transplant Applied Genomics Centre, Edmonton, AB, Canada.
INTERCOMEX Investigators
Medical University of Vienna · ATInstitute of Clinical and Experimental Medicine · CZMedical University of Warsaw · PLMedizinische Hochschule Hannover · DEThe Metabolomics Innovation Centre · CAUniversity of Alberta · CAUniversity of Maryland, Baltimore · USVirginia Commonwealth University · USWojewódzki Szpital Zespolony · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

All transplanted kidneys are subjected to some degree of injury as a result of the donation-implantation process and various post-transplant stresses such as rejection. Because transplants are frequently biopsied, they present an opportunity to explore the full spectrum of kidney response-to-wounding from all causes. Defining parenchymal damage in transplanted organs is important for clinical management because it determines function and survival. In this study, we classified the scenarios associated with parenchymal injury in genome-wide microarray results from 1,526 kidney transplant indication biopsies collected during the INTERCOMEX study. We defined injury groups by using archetypal analysis (AA) of scores for gene sets and classifiers previously identified in various injury states. Six groups and their characteristics were defined in this population: No injury, minor injury, two classes of acute kidney injury ("AKI," AKI1, and AKI2), chronic kidney disease (CKD), and CKD combined with AKI. We compared the two classes of AKI, namely, AKI1 and AKI2. AKI1 had a poor function and increased parenchymal dedifferentiation but minimal response-to-injury and inflammation, instead having increased expression of PARD3, a gene previously characterized as being related to epithelial polarity and adherens junctions. In contrast, AKI2 had a poor function and increased response-to-injury, significant inflammation, and increased macrophage activity. In random forest analysis, the most important predictors of function (estimated glomerular filtration rate) and graft loss were injury-based molecular scores, not rejection scores. AKI1 and AKI2 differed in 3-year graft survival, with better survival in the AKI2 group. Thus, injury archetype analysis of injury-induced gene expression shows new heterogeneity in kidney response-to-wounding, revealing AKI1, a class of early transplants with a poor function but minimal inflammation or response to injury, a deviant response characterized as PC3, and an increased risk of failure. Given the relationship between parenchymal injury and kidney survival, further characterization of the injury phenotypes in kidney transplants will be important for an improved understanding that could have implications for understanding native kidney diseases (ClinicalTrials.gov #NCT01299168).

Indexed as

archetypesbiopsygene expressioninjurykidney transplantation

Identifiers

PMID35463013
PMCPMC9021747
OpenAlexW4225638055

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.